Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists

Latest Eversept Partners, LP Stock Portfolio

$1.46Billion– No. of Holdings #72

Eversept Partners, LP Performance:
2024 Q2: 1.87%YTD: 19.63%2023: 3.59%

Performance for 2024 Q2 is 1.87%, and YTD is 19.63%, and 2023 is 3.59%.

About Eversept Partners, LP and 13F Hedge Fund Stock Holdings

In it's latest 13F Holdings report, Eversept Partners, LP reported an equity portfolio of $1.5 Billions as of 30 Jun, 2024.

The top stock holdings of Eversept Partners, LP are , NTRA, INSM. The fund has invested 9.1% of it's portfolio in GSK PLC and 8.7% of portfolio in NATERA INC.

The fund managers got completely rid off PFIZER INC (PFE), SHOCKWAVE MED INC (SWAV) and TENET HEALTHCARE CORP (THC) stocks. They significantly reduced their stock positions in STOKE THERAPEUTICS INC (STOK), GUARDANT HEALTH INC (GH) and SERES THERAPEUTICS INC (MCRB). Eversept Partners, LP opened new stock positions in INSMED INC (INSM), SPDR SER TR (BIL) and ARCUTIS BIOTHERAPEUTICS INC (ARQT). The fund showed a lot of confidence in some stocks as they added substantially to REPLIGEN CORP (RGEN), VIKING THERAPEUTICS INC (VKTX) and VIRIDIAN THERAPEUTICS INC (VRDN).
Eversept Partners, LP Equity Portfolio Value
Last Reported on: 14 Aug, 2024

Eversept Partners, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Eversept Partners, LP made a return of 1.87% in the last quarter. In trailing 12 months, it's portfolio return was 26.21%.

New Buys

Ticker$ Bought
insmed inc77,424,400
spdr ser tr9,271,000
arcutis biotherapeutics inc7,791,980
cytokinetics inc6,874,200
evolus inc6,232,910
oscar health inc4,918,330
cerevel therapeutics hldng i4,498,310
myriad genetics inc4,450,770

New stocks bought by Eversept Partners, LP

Additions to existing portfolio by Eversept Partners, LP

Reductions

Ticker% Reduced
stoke therapeutics inc-78.87
guardant health inc-77.9
seres therapeutics inc-69.89
immunovant inc-63.64
vaxcyte inc-51.31
merus n v-44.36
argenx se-36.55
natera inc-34.00

Eversept Partners, LP reduced stake in above stock

Sold off

Ticker$ Sold
taysha gene therapies inc-6,674,450
pfizer inc-30,581,700
curevac n v-1,562,540
taro pharmaceutical inds ltd-11,158,300
tenet healthcare corp-18,460,600
morphosys ag-3,009,860
corbus pharmaceuticals hldgs-3,489,770
shockwave med inc-26,231,100

Eversept Partners, LP got rid off the above stocks

Sector Distribution

Eversept Partners, LP has about 81.7% of it's holdings in Healthcare sector.

Sector%
Healthcare81.7
Others18.1

Market Cap. Distribution

Eversept Partners, LP has about 40% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
LARGE-CAP38.5
MID-CAP24.2
UNALLOCATED18.9
SMALL-CAP14.7
MICRO-CAP2.2
MEGA-CAP1.5

Stocks belong to which Index?

About 48.9% of the stocks held by Eversept Partners, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
Others51.1
RUSSELL 200036.4
S&P 50012.5
Top 5 Winners (%)%
INSM
insmed inc
151.9 %
UTHR
united therapeutics corp del
37.3 %
GH
guardant health inc
21.1 %
PTGX
protagonist therapeutics inc
20.4 %
BCRX
biocryst pharmaceuticals inc
19.9 %
Top 5 Winners ($)$
INSM
insmed inc
46.7 M
NTRA
natera inc
28.5 M
UTHR
united therapeutics corp del
21.5 M
TEVA
teva pharmaceutical inds ltd
12.9 M
PTGX
protagonist therapeutics inc
3.0 M
Top 5 Losers (%)%
GTHX
g1 therapeutics inc
-43.7 %
KPTI
karyopharm therapeutics inc
-42.5 %
STRO
sutro biopharma inc
-40.8 %
NVRO
nevro corp
-37.7 %
PBYI
puma biotechnology inc
-36.9 %
Top 5 Losers ($)$
INSP
inspire med sys inc
-37.8 M
VERA
vera therapeutics inc
-13.1 M
SNDX
syndax pharmaceuticals inc
-10.3 M
RGEN
repligen corp
-7.0 M
STRO
sutro biopharma inc
-3.5 M

Eversept Partners, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Eversept Partners, LP

Eversept Partners, LP has 72 stocks in it's portfolio. About 54.8% of the portfolio is in top 10 stocks. INSP proved to be the most loss making stock for the portfolio. INSM was the most profitable stock for Eversept Partners, LP last quarter.

Last Reported on: 14 Aug, 2024
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions